Leyden Labs provides a platform that targets commonalities of viral families to protect humanity from known and future viruses. Leyden Labs aims to help people live their lives to the fullest. Its platform targets commonalities of viral families to protect humanity from known and future viruses. Its portfolio of accessible intranasal product candidates may provide people with the freedom to immediately protect themselves from and prevent the spread of many strains of respiratory viruses, including ones in influenza and coronavirus families.
Biotechnology, Life Science, Therapeutics
Above €25 million
💡 You’re a corporate or investor and looking for startups that are innovating in the same market as Leyden Labs? We’re happy to assist you with our Startup Sourcing service.